Status:
RECRUITING
Molecular Characterisation of Appendiceal Cancer
Lead Sponsor:
The Christie NHS Foundation Trust
Collaborating Sponsors:
University of Manchester
Conditions:
Appendiceal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Patients ≥ 18 years old who have been diagnosed with appendiceal cancer with peritoneal metastases, have had cytoreductive surgery, have availability of archival tumour tissue and have consented to ou...
Detailed Description
Appendiceal cancer is a rare and understudied cancer that frequently leads to metastatic disease with production of copious gelatinous collections in the abdomen, causing severe illness and poor survi...
Eligibility Criteria
Inclusion
- Participants are eligible to be included in the study only if all of the following criteria apply:
- Patients ≥ 18 years old who have been diagnosed with appendiceal cancer with peritoneal metastases,
- have had cytoreductive surgery
- have availability of archival tumour tissue
Exclusion
- None
Key Trial Info
Start Date :
February 4 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 3 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05364788
Start Date
February 4 2024
End Date
July 3 2025
Last Update
January 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Christie NHS Foundation Trust
Manchester, United Kingdom